Question 1

What specific benefits might I expect from participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Trial to Determine the Immunomodulatory Activity of PTM-001 in Patients With Hidradenitis Suppurativa clinical trial (NCT05020730). Contact the study team or your healthcare provider for specific answers.

Question 2

How does PTM-001 compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Trial to Determine the Immunomodulatory Activity of PTM-001 in Patients With Hidradenitis Suppurativa clinical trial (NCT05020730). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of PTM-001?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Trial to Determine the Immunomodulatory Activity of PTM-001 in Patients With Hidradenitis Suppurativa clinical trial (NCT05020730). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to visit the clinic during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Trial to Determine the Immunomodulatory Activity of PTM-001 in Patients With Hidradenitis Suppurativa clinical trial (NCT05020730). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects while on PTM-001?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Trial to Determine the Immunomodulatory Activity of PTM-001 in Patients With Hidradenitis Suppurativa clinical trial (NCT05020730). Contact the study team or your healthcare provider for specific answers.

Question 6

Will I have access to PTM-001 after the trial ends?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Trial to Determine the Immunomodulatory Activity of PTM-001 in Patients With Hidradenitis Suppurativa clinical trial (NCT05020730). Contact the study team or your healthcare provider for specific answers.

What this study is about